Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial Meeting Abstract


Authors: Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; Glade Bender, J.; Kothari, P.; Heaton, T.; LaQuaglia, M.; Price, A.; Meyers, P.
Abstract Title: Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial
Meeting Title: 51st Congress of the International Society of Paediatric Oncology (SIOP)
Journal Title: Pediatric Blood and Cancer
Volume: 66
Issue: Suppl. 4
Meeting Dates: 2019 Oct 23-26
Meeting Location: Lyon, France
ISSN: 1545-5009
Publisher: Wiley Periodicals, Inc  
Date Published: 2019-12-01
Start Page: S292
End Page: S293
Language: English
ACCESSION: WOS:000488458003119
PROVIDER: wos
PUBMED: 31568621
DOI: 10.1002/pbc.27989
Notes: Meeting Abstract: V262 SIOP19-1718 -- Source: Wos
Altmetric
Citation Impact